Zynyz
Term · Oncology and biomedicine · MLC-T-ONC-009506
A drug used to treat adults with Merkel cell carcinoma (a type of skin cancer) that has come back or has spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Zynyz binds to a protein called PD-1, which is found on T cells (a type of immune cell). Zynyz may block PD-1 and help the immune system kill cancer cells. It is a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called retifanlimab.
| Identifier | MLC-T-ONC-009506 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | retifanlimab |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009506",
"term": "Zynyz",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults with Merkel cell carcinoma (a type of skin cancer) that has come back or has spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Zynyz binds to a protein called PD-1, which is found on T cells (a type of immune cell). Zynyz may block PD-1 and help the immune system kill cancer cells. It is a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called retifanlimab.",
"synonyms": [
"retifanlimab"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/zynyz/"
}
Record 17,714 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.